Vimian Group AB (publ) (STO: VIMIAN)

Sweden flag Sweden · Delayed Price · Currency is SEK
42.85
+1.45 (3.50%)
Aug 30, 2024, 5:29 PM CET
40.77%
Market Cap 22.39B
Revenue (ttm) 3.91B
Net Income (ttm) 111.44M
Shares Out 522.42M
EPS (ttm) 0.23
PE Ratio 184.76
Forward PE 36.80
Dividend n/a
Ex-Dividend Date n/a
Volume 473,286
Open 41.70
Previous Close 41.40
Day's Range 41.20 - 42.85
52-Week Range 20.08 - 43.50
Beta 1.54
Analysts n/a
Price Target n/a
Earnings Date Oct 24, 2024

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I... [Read more]

Sector Healthcare
Founded 2020
Employees 1,100
Stock Exchange Nasdaq Stockholm
Ticker Symbol VIMIAN
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.